DACLATASVIR\SOFOSBUVIR: 14 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
14
Total FAERS Reports
2 (14.3%)
Deaths Reported
4
Hospitalizations
14
As Primary/Secondary Suspect
2
Life-Threatening
First Report: 201810 · Latest Report: 201810
What Are the Most Common DACLATASVIR\SOFOSBUVIR Side Effects?
#1 Most Reported
Hepatitis b reactivation
5 reports (35.7%)
#2 Most Reported
Off label use
2 reports (14.3%)
#3 Most Reported
Hypertransaminasaemia
2 reports (14.3%)
All DACLATASVIR\SOFOSBUVIR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatitis b reactivation | 5 | 35.7% | 0 | 0 |
Who Reports DACLATASVIR\SOFOSBUVIR Side Effects? Age & Gender Data
Gender: 46.2% female, 53.8% male. Average age: 59.8 years. Most reports from: COUNTRY NOT SPECIFIED. View detailed demographics →
Is DACLATASVIR\SOFOSBUVIR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 1 | 0 | 0 |
What Is DACLATASVIR\SOFOSBUVIR Used For?
| Indication | Reports |
|---|---|
| Chronic hepatitis c | 6 |
Official FDA Label for DACLATASVIR\SOFOSBUVIR
Official prescribing information from the FDA-approved drug label.